Management has the ability, if necessary, to liquidate any of its investments in order to meet the Company’s liquidity needs in the next 12 months.
The net increase was primarily attributable to the addition of historical gross unrecognized tax benefits for ESI as a result of the ESI Merger during the quarter ended March 31, 2019.
The market participants usually are large commercial banks.
This correction, which was recorded during the quarter ended June 30, 2019, but should have been recorded during the three months ended September 30, 2018, increased the Company’s effective tax rate for the three and six months ended June 30, 2019 and the nine months ended September 30, 2019 by 9.8%, 7.5% and
The Company’s primary served markets include semiconductor, industrial technologies, life and health sciences, and research and defense.
step-up amortization from the three and nine month periods ended September 30, 2019 and the addition of these items to the three and nine month periods ended September 30, 2018.
ended September 30, 2018, respectively.
The exclusion of debt issuance costs due to the modification of the 2019 Incremental Term Loan Facility from the three and nine month periods ended September 30, 2019 and the addition of this item to the three and nine month periods ended September 30, 2018.
During the third quarter of 2019, the Company identified adjustments related to our unaudited pro forma disclosures that were reported during the first and second quarters of 2019.
The Company is a global provider of instruments, subsystems and process control solutions that measure, monitor, deliver, analyze, power and control critical parameters of advanced manufacturing processes to improve process performance and productivity for its customers.
The Company’s effective tax rates for the three and nine months ended September 30, 2018 were 18.5% and 17.6%, respectively.
There were no SARs granted during the nine months ended September 30, 2019 or 2018.We believe that the continued investment in research and development and ongoing development of new products are essential to the expansion of our markets.
Many of our leases contain options to renew and extend lease terms, and options to terminate leases early.
Selling, general and administrative expenses increased by $11.3 million for the three months ended September 30, 2019, compared to the same period in the prior year.
out-of-period error with respect to deferred tax assets related to limitations on the deduction of executive compensation in the amount of $5.0 million.
We have not borrowed against this ABL Facility to date.
non-current liabilities of $3.0 million.
This decrease primarily related to the use of $406.0 million of cash to fund the payment of a portion of the purchase price for ESI on February 1, 2019.On May 1, 2019, the Court granted the defendants’ motion to strike plaintiffs’ jury demand and determined that the case will be tried by the Court, and not a jury.